Adoption of minimally invasive surgery after neoadjuvant chemotherapy in women with metastatic uterine cancer

Zhou, Z. N., Chen, L., Melamed, A., St. Clair, C. M., Hou, J. Y., Khoury-Collado, F., Gockley, A., Hershman, D. L., & Wright, J. D. (2022). Adoption of minimally invasive surgery after neoadjuvant chemotherapy in women with metastatic uterine cancer. Gynecologic Oncology, 164(2), 341–347. https://doi.org/10.1016/j.ygyno.2021.12.005
Authors:
Zhen Ni Zhou
Ling Chen
Alexander Melamed
Caryn M. St. Clair
June Y. Hou
Fady Khoury-Collado
Allison Gockley
Dawn L. Hershman
Jason D. Wright
Affiliated Authors:
Zhen Ni Zhou
Ling Chen
Alexander Melamed
Caryn M. St. Clair
June Y. Hou
Fady Khoury-Collado
Allison Gockley
Dawn L. Hershman
Jason D. Wright
Columbia Affiliation:
Subjects:
Carcinoma, Endometrioid (MeSH)
Carcinosarcoma (MeSH)
Cytoreduction Surgical Procedures (MeSH)
Hysterectomy (MeSH)
Minimally Invasive Surgical Procedures (MeSH)
Neoadjuvant Therapy (MeSH)
Neoplasms, Cystic, Mucinous, and Serous (MeSH)
Uterine Neoplasms (MeSH)
Author Keywords:
cytoreduction
debulking
endometrial cancer
hysterctomy
uterine cancer
elink
Publication Type:
Article
Unique ID:
10.1016/j.ygyno.2021.12.005
PMID:
34920885
DOI:
10.1016/j.ygyno.2021.12.005
Journal:
Gynecologic Oncology
Publication Date:
Data Source:
Scopus
Source Link:
View Scopus Record
View Web of Science Record
View PubMed Record

Record Created: